Anh, Pham Thi QueLan, Tran PhuongLinh, Truong ThuyNhung, Tran PhuongVietnam. Ministry of Industry and Trade, Competition Administration Department2009-07-152009-07-152009http://hdl.handle.net/10625/39220In the context of Vietnam’s integration into world economies, new concerns arise in access to medicines and healthcare. Anti-competitive practices in the pharmaceutical industry include price fixing, abuse of market dominance, collusive agreements, and tied selling. The project aims to promote public welfare in Vietnam through ensuring and enhancing access to medicines and health delivery systems. This in-depth report identifies competition concerns in the pharmaceutical sector and health systems, and examines the scope of competition policy and law in dealing with such concerns. Recommendations are made for specific legal provisions, and state agencies’ regulatory role.Text1 digital file (184 p. : ill.)enPHARMACEUTICAL DISTRIBUTION IN VIETNAMCOMPETITION POLICY AND REGULATIONSPHARMACEUTICAL INDUSTRYUNFAIR COMPETITIONVIET NAMIDRC Final Report